NasdaqGS - Delayed Quote USD
Prelude Therapeutics Incorporated (PRLD)
0.9601
-0.0799
(-7.68%)
At close: June 13 at 4:00:00 PM EDT
0.9500
-0.01
(-1.05%)
After hours: June 13 at 6:08:44 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COMBS ANDREW P Officer | Purchase | Mar 25, 2025 | 480,123 |
| HUANG JANE President | Conversion of Exercise of derivative security | Apr 4, 2025 | 74,877 |
| LIM BRYANT DAVID Chief Financial Officer | Purchase | Dec 19, 2024 | 27,400 |
| VADDI KRISHNA Chief Executive Officer | Purchase | Mar 25, 2025 | 3,669,050 |
Related Tickers
FHTX Foghorn Therapeutics Inc.
4.3200
-4.85%
PMVP PMV Pharmaceuticals, Inc.
1.0800
-0.92%
NRIX Nurix Therapeutics, Inc.
11.93
-0.25%
CCCC C4 Therapeutics, Inc.
1.6800
+3.70%
ITOS iTeos Therapeutics, Inc.
10.17
+1.90%
STTK Shattuck Labs, Inc.
1.0100
-5.61%
PASG Passage Bio, Inc.
0.3910
-9.43%
ZNTL Zentalis Pharmaceuticals, Inc.
1.3400
-8.22%
NXTC NextCure, Inc.
0.6810
+4.48%
RLAY Relay Therapeutics, Inc.
3.2200
-6.67%